Table 1: Baseline Clinical and Fasting Laboratory Characteristics of Male Patients with type 2 Diabetes Mellitus

Group A (n=26) Group B (n=15) p
Hypertension (%) 57.7 73.3 ns
Statin use (%) 42.3 53.3 ns
CVD (%) 42.3 20 ns
Smoking (%) 38.5 20 ns
Age (years) 66.9±8.1 68.1±6.8 ns
Weight (kg) 74.6±14 77.4±9.5 ns
Height (m) 1.7±0.1 1.7±0.1 ns
BMI (kg/m2) 26.4±4.1 27.6±3.2 ns
Waist circumference (cm) 97.9±12.8 97.3±7.8 ns
Body fat (%) 31.8±9.6 41.3±10 0.005
Duration of diabetes (years) 12.8±7.5 10.9±9.5 ns
SBP (mmHg) 131.5±22 136.3±18.1 ns
DBP(mmHg) 78.5±15.2 76.3±11.1 ns
WCC (x103/µl) 7319±1805 6311±1896 ns
Uric acid (mg/dl) 5.3±1.5 5.6±1.2 ns
TC (mg/dl) 193±36 157±37 0.005
TG (mg/dl) 172±91 109±34 0.012
HDL-C (mg/dl) 47±12 45±10 ns
LDL-C (mg/dl) 112±32 90±30 ns
AST (u/l) 20±10 22±12 ns
ALT (u/l) 22±12 45±81 ns
CK (u/l) 69±39 135±159 ns
Gamma-GT (u/l) 31
(12-138)
19
(8-304)
0.012
Glucose (mg/dl) 216±79 131±25 N/A
HbA1c (%) 9.8±1.7 6±0.9 N/A
Cr (mg/dl) 1±0.3 0.9±0.2 ns
Leptin (ng/ml) 7.6±7.4 4.3±2.3 ns
Adiponectin (µg/ml) 11.5±8.4 15.6±9.7 ns
Ghrelin (pg/ml) 874±292 810±176 ns
NPY (pmol/L) 156.5±57.8 127.4±29.5 ns
MDRD eGFR (mL/min/1.73m2) 84.5±22.8 96.6±22.4 ns
Cockroft-Gault creatinine clearance (mL/min) 79.9±26.2 91.6±22.6 ns

CVD: cardiovascular disease (coronary heart disease and/or stroke); BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure; WCC: white cell count; TC: total cholesterol; TG: triglyceride; HDL-C: high density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; AST: aspartate transaminase; ALT: alanine transaminase; CK: creatine kinase; gamma-GT: gamma glutamyl transpeptidase; Cr: creatinine; NPY: neuropeptide Y; MDRD: modification of diet in renal disease; eGFR: estimated glomerular filtration rate; N/A: not applicable.